Cite
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
MLA
Van Neste, Leander, et al. “Detection of High-Grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.” European Urology, vol. 70, no. 5, Nov. 2016, pp. 740–48. EBSCOhost, https://doi.org/10.1016/j.eururo.2016.04.012.
APA
Van Neste, L., Hendriks, R. J., Dijkstra, S., Trooskens, G., Cornel, E. B., Jannink, S. A., de Jong, H., Hessels, D., Smit, F. P., Melchers, W. J. G., Leyten, G. H. J. M., de Reijke, T. M., Vergunst, H., Kil, P., Knipscheer, B. C., Hulsbergen-van de Kaa, C. A., Mulders, P. F. A., van Oort, I. M., Van Criekinge, W., & Schalken, J. A. (2016). Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score. European Urology, 70(5), 740–748. https://doi.org/10.1016/j.eururo.2016.04.012
Chicago
Van Neste, Leander, Rianne J Hendriks, Siebren Dijkstra, Geert Trooskens, Erik B Cornel, Sander A Jannink, Hans de Jong, et al. 2016. “Detection of High-Grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.” European Urology 70 (5): 740–48. doi:10.1016/j.eururo.2016.04.012.